title: Do the mechanisms by which LDL-c levels are reduced influence the extent of clinical benefit which subsequently accrues?
authors.affiliation: aSt George's Medical School, University of London, London bUniversity Hospital of Wales, Cardiff, UK.
authors.forename: Catrin A
authors.initials: CA
authors.lastname: Higgins
authors.forename: Alan
authors.initials: A
authors.lastname: Rees
mesh_terms: D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D050197:Atherosclerosis / Q000097:blood / Q000188:drug therapy*; D008078:Cholesterol, LDL / Q000097:blood*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
chemical_list: D000924:Anticholesteremic Agents; D008078:Cholesterol, LDL